Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SCN4A | P35499 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11225356 | 0.84 | ADRB2 (0.57) | LMNAMAOAPTGS1CYP2D6ADRB2 | |
| SCHEMBL17171595 | 0.79 | LMNA (0.57) | LMNAMAOAPTGS1SCN4ALTA4H | |
| SCHEMBL17034727 | 0.78 | CYP2C9 (0.55) | LMNAMAOAPTGS1SCN4AMTNR1A | |
| SCHEMBL12172005 | 0.78 | LMNA (0.43) | LMNAMAOAPTGS1SCN4ALTA4H | |
| SCHEMBL9464093 | 0.78 | MTNR1A (0.50) | LMNAMTNR1AMTNR1B | |
| SCHEMBL19944683 | 0.77 | LTA4H (0.57) | LMNAMAOAPTGS1SCN4ALTA4H | |
| SCHEMBL17395999 | 0.77 | LMNA (0.50) | LMNAMAOAPTGS1SCN4ALTA4H | |
| SCHEMBL43037 | 0.77 | KCNA3 (0.52) | LMNALTA4HKCNA3 | |
| SCHEMBL9463999 | 0.76 | LMNA (0.46) | LMNAMTNR1AMTNR1B | |
| SCHEMBL8670088 | 0.74 | LMNA (0.47) | LMNAMAOAPTGS1SCN4ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |